AveXis, Gene Therapy Development Company, Expands Program
Source: Pixabay

AveXis, Gene Therapy Development Company, Expands Program

The gene therapy development company, AveXis, Incorporation, just announced that they will be expanding their clinical trial development program for the potential gene therapy treatment: AVXS-101, reported Globe News Wire.…

Continue Reading AveXis, Gene Therapy Development Company, Expands Program
Parents Sue Hospital and Social Services Over Treatment Of Their 11-Year-Old Daughter with Rett Syndrome
Source: Pixabay

Parents Sue Hospital and Social Services Over Treatment Of Their 11-Year-Old Daughter with Rett Syndrome

The Driscoll family is left devastated and shocked after receiving a letter from social services that states the government could be taking their daughter, who is suffering from Rett syndrome,…

Continue Reading Parents Sue Hospital and Social Services Over Treatment Of Their 11-Year-Old Daughter with Rett Syndrome
The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs
source: pixabay.com

The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs

According to an article from PRNewswire, the drug MVASI (biosimilar bevacizumab) was just granted marketing authorization by the European Commission. Developed by Amgen and Allergan, this treatment has been approved…

Continue Reading The European Commission Just Approved MVASI, One of The First Biosimilar Cancer Drugs
Extreme Athlete Anthony Anzell Doesn’t Let His Hereditary Hemmorhagic Telangiectasia Slow Him Down
Source: Pixabay

Extreme Athlete Anthony Anzell Doesn’t Let His Hereditary Hemmorhagic Telangiectasia Slow Him Down

Reported by Fox 2, Anthony Anzell doesn’t let his rare genetic disease hold him back. Anthony is an extreme athlete who just swam 19 miles, the entire length of Torch…

Continue Reading Extreme Athlete Anthony Anzell Doesn’t Let His Hereditary Hemmorhagic Telangiectasia Slow Him Down
PTC Therapeutics Continue To Fight For Duchenne Muscular Dystrophy Community
Source: Pixabay

PTC Therapeutics Continue To Fight For Duchenne Muscular Dystrophy Community

Even after the third denial from the U.S. FDA, Food and Drug Administration, PTC Therapeutics Incorporation will not stop fighting for the drug Translarna that they believe will help patients…

Continue Reading PTC Therapeutics Continue To Fight For Duchenne Muscular Dystrophy Community
ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis
Source: Pixabay

ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis

The FDA, US Food and Drug Administration, unanimously agreed upon the recommendation for a new gene therapy that treats a rare form of blindness, reported ScienceNordic. Spark Therapeutics, a biotech…

Continue Reading ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis
Turning Skin Cells Into Muscle Cells: Treatment for Muscular Disorders
Source: pixabay.com

Turning Skin Cells Into Muscle Cells: Treatment for Muscular Disorders

There is potential for a new treatment for Duchenne muscular dystrophy. Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness.To learn more about this…

Continue Reading Turning Skin Cells Into Muscle Cells: Treatment for Muscular Disorders